Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Jul;78(1):170–176. doi: 10.1172/JCI112547

Characterization of a variant prekallikrein, prekallikrein Long Beach, from a family with mixed cross-reacting material-positive and cross-reacting material-negative prekallikrein deficiency.

B N Bouma, D M Kerbiriou, J Baker, J H Griffin
PMCID: PMC329546  PMID: 3487556

Abstract

Studies of plasma prekallikrein in a family with prekallikrein deficiency were made. Three children had no clotting activity but approximately 35% antigen levels, and the mother and five children had twice as much prekallikrein antigen as clotting activity, suggesting the presence of a dysfunctional molecule. A nonfunctional variant form of prekallikrein was purified that contained no prekallikrein clotting activity. The variant and normal molecules were both 80,000 mol wt, immunologically indistinguishable and complexed similarly with high molecular weight kininogen. Isoelectric focusing studies suggested a difference of one charged amino acid residue. The variant was cleaved by beta-Factor XIIa 200 times slower than the normal molecule, and no amidolytic activity was detected for the cleaved variant. These data and other observations suggest that an amino acid was substituted in the variant near the NH2-terminal end of the kallikrein light chain resulting in slower cleavage by beta-Factor XIIa and the absence of enzymatic activity.

Full text

PDF
170

Images in this article

172Image
on p.172
173Image
on p.173
173Image
on p.173
174Image
on p.174
175Image
on p.175

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abildgaard C. F., Harrison J. Fletcher factor deficiency: family study and detection. Blood. 1974 May;43(5):641–644. [PubMed] [Google Scholar]
  2. Aznar J. A., España F., Aznar J., Tascon A., Jimenez C. Fletcher factor deficiency: report of a new family. Scand J Haematol. 1978 Aug;21(2):94–98. doi: 10.1111/j.1600-0609.1978.tb02498.x. [DOI] [PubMed] [Google Scholar]
  3. Bouma B. N., Griffin J. H. Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. J Biol Chem. 1977 Sep 25;252(18):6432–6437. [PubMed] [Google Scholar]
  4. Bouma B. N., Kerbiriou D. M., Vlooswijk R. A., Griffin J. H. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation. J Lab Clin Med. 1980 Oct;96(4):693–709. [PubMed] [Google Scholar]
  5. Bouma B. N., Miles L. A., Beretta G., Griffin J. H. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate. Biochemistry. 1980 Mar 18;19(6):1151–1160. doi: 10.1021/bi00547a018. [DOI] [PubMed] [Google Scholar]
  6. Derkx F. H., Bouma B. N., Schalekamp M. P., Schalekamp M. A. An intrinsic factor XII- prekallikrein-dependent pathway activates the human plasma renin-angiotensin system. Nature. 1979 Jul 26;280(5720):315–316. doi: 10.1038/280315a0. [DOI] [PubMed] [Google Scholar]
  7. Essien E. M., Ebhota M. I. Fletcher factor deficiency--detection of a severe case in a population survey. Acta Haematol. 1977;58(6):353–358. doi: 10.1159/000207849. [DOI] [PubMed] [Google Scholar]
  8. Griffin J. H., Cochrane C. G. Human factor XII (Hageman factor). Methods Enzymol. 1976;45:56–65. doi: 10.1016/s0076-6879(76)45009-7. [DOI] [PubMed] [Google Scholar]
  9. Hathaway W. E., Belhasen L. P., Hathaway H. S. Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. Blood. 1965 Nov;26(5):521–532. [PubMed] [Google Scholar]
  10. Hattersley P. G., Hayse D. Fletcher factor deficiency: a report of three unrelated cases. Br J Haematol. 1970 Apr;18(4):411–416. doi: 10.1111/j.1365-2141.1970.tb01454.x. [DOI] [PubMed] [Google Scholar]
  11. Hojima Y., Pierce J. V., Pisano J. J. Purification and characterization of multiple forms of human plasma prekallikrein. J Biol Chem. 1985 Jan 10;260(1):400–406. [PubMed] [Google Scholar]
  12. Kerbiriou D. M., Bouma B. N., Griffin J. H. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein. J Biol Chem. 1980 May 10;255(9):3952–3958. [PubMed] [Google Scholar]
  13. Kerbiriou D. M., Griffin J. H. Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma. J Biol Chem. 1979 Dec 10;254(23):12020–12027. [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. Laake K., Venneröd A. M. Factor XII-induced fibrinolysis: studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma. Thromb Res. 1974 Feb;4(2):285–302. doi: 10.1016/0049-3848(74)90093-0. [DOI] [PubMed] [Google Scholar]
  16. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  17. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  18. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  19. Saito H., Goodnough L. T., Soria J., Soria C., Aznar J., España F. Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material. N Engl J Med. 1981 Oct 15;305(16):910–914. doi: 10.1056/NEJM198110153051602. [DOI] [PubMed] [Google Scholar]
  20. Saito H., Ratnoff O. D., Donaldson V. H. Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma. Circ Res. 1974 May;34(5):641–651. doi: 10.1161/01.res.34.5.641. [DOI] [PubMed] [Google Scholar]
  21. Sealey J. E., Atlas S. A., Laragh J. H., Silverberg M., Kaplan A. P. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5914–5918. doi: 10.1073/pnas.76.11.5914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Weiss A. S., Gallin J. I., Kaplan A. P. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. J Clin Invest. 1974 Feb;53(2):622–633. doi: 10.1172/JCI107597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wuepper K. D. Prekallikrein deficiency in man. J Exp Med. 1973 Dec 1;138(6):1345–1355. doi: 10.1084/jem.138.6.1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. van der Graaf F., Tans G., Bouma B. N., Griffin J. H. Isolation and functional properties of the heavy and light chains of human plasma kallikrein. J Biol Chem. 1982 Dec 10;257(23):14300–14305. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES